Bhutan vs Cambodia: Average cost of multi drug-resistant tuberculosis treatment
Bhutan
886 constant 2022 US$
in 2024
Cambodia
850 constant 2022 US$
in 2024
Bhutan rank
55th
Cambodia rank
58th
Average cost of multi drug-resistant tuberculosis treatment over time
- Bhutan
- Cambodia
How they compare
Bhutan currently reports 886 constant 2022 US$ against 850 constant 2022 US$ in Cambodia, a difference of 36 constant 2022 US$.
The two have swapped places 1 time across 7 shared years of data; in 2017 it was Cambodia ahead.
Bhutan ranks 55th and Cambodia ranks 58th of 92 countries.
Cambodia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bhutan | Cambodia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,204 constant 2022 US$ | 2,247 constant 2022 US$ | 1,043 constant 2022 US$ | Cambodia |
| 2020s | 859 constant 2022 US$ | 1,688 constant 2022 US$ | 828.5 constant 2022 US$ | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Bhutan or Cambodia?
- Bhutan, at 886 constant 2022 US$ against 850 constant 2022 US$ in Cambodia as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Bhutan and Cambodia?
- 36 constant 2022 US$, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Cambodia?
- 7 years are reported by both, from 2017 to 2024.
- How do Bhutan and Cambodia rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Bhutan ranks 55th and Cambodia ranks 58th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.